Walmart (NYSE:WMT) shares gained ground Monday, after it announced the expansion of its HIV Point-of-Care Screenings to 18 Specialty Pharmacies of the Community (SPOCs) – located within Walmart Pharmacies – in Colorado and Virginia, just ahead of National HIV Testing Day on June 27. These screenings are part of Walmart’s continued effort to make healthcare more accessible, affordable and convenient, following the HIV screening pilot at two Walmart pharmacies in Virginia last year. Screenings at all 20 locations are free to patients as part of a continued pilot expansion that runs through Sept. 27.
This testing is all provided within Walmart’s SPOCs, which help patients with aspects of care, including industry-leading clinical programs, HIV-trained pharmacists performing at the top of their license, custom-care coordination and healthy lifestyle recommendations. Continuing our commitment to holistic care, Walmart’s specialty pharmacists can help you manage your medications, find emotional support, and navigate insurance options. They make treatment easier, more convenient and discreet for HIV patients to manage their healthcare needs, focused on each individual patient.
“We remain on a dedicated journey to broaden access to HIV care while also doing our part to reduce the stigma associated with HIV,” said Kevin Host, Senior Vice President of Pharmacy at Walmart. “Our newest HIV Point-of-Care Screening locations are led by pharmacists who are uniquely positioned to support those who are undiagnosed and experiencing symptoms during a time of uncertainty.”
WMT shares picked up 38 cents to $68.29.
